TrialJournal of clinical pharmacology2020

Efficacy, Safety, and Tolerability of ONO-4474, an Orally Available Pan-Tropomyosin Receptor Kinase Inhibitor, in Japanese Patients With Moderate to Severe Osteoarthritis of the Knee: A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Comparative Study.

Naoki Ishiguro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.